Akèy › Trè selil fòs
Etid klinik pou Trè selil fòs ap rekrite nan Etazini
7 etid pou Trè selil fòs ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Blood Sampling for Research Related to Sickle Cell Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 100 · Tout sèks · Mizajou Sep 29, 2026 · NCT00542230A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Ap rekriteFaz 3
Laj 12 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT06439082Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Sep 17, 2026 · NCT05904093131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
Ap rekriteFaz 1
Laj 12 a 50 · Tout sèks · Mizajou Jun 10, 2026 · NCT07015684Sickle Cell Kidney Biorepository
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Apr 13, 2026 · NCT07064174Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Nov 6, 2025 · NCT06071377Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 50 ak plis · Fanm · Mizajou Jul 24, 2025 · NCT07083531Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.